Patient Guide: Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 34 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07007052
Status: NOT_YET_RECRUITING
Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Phase: PHASE2

Find a Study Location Near You

This study is available at 34 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Amiens,
  • Angers,
  • Argenteuil,
  • • And 31 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily